Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eryxin
- Development stage
- Phase 1
- Lead developer
- Namangan Pharm Plant
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Eryxin is a plant-derived therapeutic developed by Namangan Pharm Plant LTD in Uzbekistan, primarily investigated for the treatment of rheumatoid arthritis. It is a standardized extract derived from the plant *Ferula foetida* (commonly known as Asafoetida), specifically containing a complex of esters of the sesquiterpene alcohol ferutriol. The drug is hypothesized to exert anti-inflammatory and immunomodulatory effects, potentially by inhibiting the production of pro-inflammatory cytokines and modulating the immune response in autoimmune conditions. In clinical studies, Eryxin has been evaluated as an intravenous add-on therapy to conventional treatments, such as methotrexate and tofacitinib, to assess its safety and preliminary efficacy in reducing disease activity in patients with rheumatoid arthritis.
- Brand names
- Eryxin
- Other names
- Ferula foetida extractFerutriol esters complex
Beyond the preview
Go deeper on Eryxin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eryxin.